PTC Therapeutics Wins Big With Agilis Biotherapeutics Acquisition
PTC Therapeutics shares made a handy gain on Friday after the firm announced that it would be acquiring Agilis Biotherapeutics......»»
PTC Therapeutics stock spikes on $200 million acquisition of Agilis Biotherapeutics
PTC Therapeutics said Thursday afternoon that it plans to acquire gene-therapy startup Agilis Biotherapeut.....»»
6 Stocks Moving In Thursday"s After-Hours Session
Gainers PTC Therapeutics, Inc. (NASDAQ: PTCT) shares are up 10 percent after agreeing to acquire Agilis Biotherapeutics for $50 million in cash and $150 million in common stock. read more.....»»
PTC Therapeutics (PTCT) To Acquire Agilis Biotherapeutics for $200M upfront - Slideshow
PTC Therapeutics (PTCT) To Acquire Agilis Biotherapeutics for $200M upfront - Slideshow.....»»
Blue Water Acquisition to bring Clarus Therapeutics public via merger
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Better Therapeutics to go public through Mountain Crest Acquisition merger
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen Bets On Regenerative Immunology With Rodeo Therapeutics Acquisition
With blockbuster immunology treatments Enbrel (via $16 billion acquisition of Immunex in 2009) and Otezla (added in 2013 via $13 billion deal) already in its bag, Amgen Inc (NASDAQ: AMGN) read more.....»»
Takeda To Expand Immuno-Oncology Portfolio With Maverick Therapeutics Acquisition
Takeda Pharmaceutical Co Ltd (NYSE: TAK) has read more.....»»
United Therapeutics acquired a competitor and its flagship product. Now it’s cutting bait.
The Silver Spring drugmaker inherited the asset in its 2018 acquisition of SteadyMed Therapeutics — a strategic move that pulled a competitive threat into its own corner......»»
PsyBio Announces Second Quarter Financial Results of Leo Acquisition Corp.
TORONTO, March 01, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (formerly Leo Acquisitions Corp.) (TSXV:PSYB) ("Psy.....»»
Beam Therapeutics completes acquisition of Guide Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
G1 Therapeutics" Trilaciclib Wins FDA Nod For Mitigating Chemo Effects In Lung Cancer Patients
read more.....»»
BridgeBio completes acquisition of Eidos Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly completes acquisition of Prevail Therapeutics
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tenax Therapeutics announces "transformative" acquisition of PH Precision Med
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bellerophon Provides Clinical Program Update and Reports Fourth Quarter and Full-Year 2019 Financial Results
WARREN, N.J., April 06, 2020 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (NASDAQ:BLPH), a clinical-stage biotherapeutics company focused on developing treatme.....»»
Morgan Stanley wins antitrust approval for E-Trade acquisition, Bloomberg says
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bellerophon Shares Catch Fire As FDA Clears Nitric Oxide Product For Coronavirus Treatment
Shares of micro-cap biotherapeutics company Bellerophon Therapeutics Inc (NASDAQ: BLPH) gap-opened higher Friday morning and were holding on to the ga read more.....»»
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
NEW YORK, March 11, 2020 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ:CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, develop.....»»
North Carolina wins 200-job project over California, Colorado
A genetics medicine company has picked Sanford over competing locations in California, Massachusetts and Colorado for a 209-job manufacturing facility. Audentes Therapeutics' Sanford site will be the second large-scale manufacturing operation for the C.....»»
Bellerophon Therapeutics Shares Rip Higher On Phase 2 Hypertension Study Results
Shares of biotherapeutics company Bellerophon Therapeutics Inc (NASDAQ: BLPH) were more than doubling Tuesday following a positive clinical readout from read more.....»»